Eko Low Ejection Fraction Tool (ELEFT) vs TeraRecon Cardiac.Chambers.MR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A is designed for early detection of low ejection fraction during routine physical exams, leveraging digital stethoscope data. In contrast, Tool B focuses on automated segmentation and volumetric analysis of cardiac chambers from MR images to aid in detailed diagnosis and treatment planning. While both contribute to cardiac care and involve ejection fraction, they utilize different data modalities and serve distinct points in the clinical workflow.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for different specialties, and what specific clinical problems do they primarily address?

Eko Low Ejection Fraction Tool (ELEFT) integrates into routine physical exams, aiding clinicians in the early detection of low ejection fraction during a non-invasive screening. It is suitable for Cardiology, Family Medicine, and Internal Medicine, addressing the early identification of heart failure risk. TeraRecon Cardiac.Chambers.MR integrates into cardiac MR imaging workflows, providing automated segmentation for detailed diagnosis and treatment planning in Cardiology and Radiology specialties.

What is the depth of EHR integration for each tool, and how does it streamline documentation and access to results?

ELEFT, as part of Eko's SENSORAu2122 platform, offers EHR integration that allows clinicians to open a dashboard within their EHR system and push AI analysis results directly via PDF or an anonymous URL, simplifying documentation. TeraRecon Cardiac.Chambers.MR outputs DICOM files, ensuring interoperability with PACS and other DICOM-compliant systems, which can then be integrated into EHRs for streamlined access to imaging results.

What level of accuracy can physicians expect from ELEFT in identifying low ejection fraction during a physical exam, and how does TeraRecon Cardiac.Chambers.MR's automated segmentation accuracy compare to manual methods for volumetric analysis?

ELEFT, trained on over 100,000 ECG and echocardiogram pairs, demonstrated a sensitivity of nearly 75% and a specificity of 77.5% for detecting LVEF less than 40% in a multi-site clinical study of 3,456 patients. TeraRecon Cardiac.Chambers.MR offers automatic segmentation of cardiac chambers from MR images, providing volumetric analysis of ejection fraction and LV/RV inner and outer contour detection, which assists in precise diagnosis and treatment planning.

What is the expected learning curve for physicians and clinical staff to effectively use each tool, and how quickly can a practice anticipate realizing clinical or operational benefits?

ELEFT integrates with familiar Eko digital stethoscopes and provides results in approximately 15 seconds, suggesting a relatively low learning curve for its use in routine physical exams and quick clinical insights. TeraRecon Cardiac.Chambers.MR involves interpreting AI-segmented MR images and offers features like automated contouring and dedicated viewers, aiming to accelerate diagnostic precision and treatment planning for faster operational benefits.

What audit-trail features are available within each tool to track AI-assisted findings and ensure accountability in clinical decision-making?

ELEFT, as part of the SENSORAu2122 platform, provides AI-powered results in the screening process, which can be pushed to EHRs as PDF reports or URLs, implying a traceable record of the AI's output. TeraRecon Cardiac.Chambers.MR outputs DICOM files that can be integrated into existing imaging archives like PACS, providing a traceable record of the automated segmentations used in diagnosis and supporting physician interaction to accept, reject, or adjust AI findings.

What are the key considerations for deploying each tool across multiple clinical sites or a larger hospital system?

ELEFT, as an enterprise solution part of the SENSORAu2122 platform, would require coordinated deployment of Eko digital stethoscopes and platform integration across various sites, including primary care settings. TeraRecon Cardiac.Chambers.MR, available as a containerized application or on a robust cloud-based SaaS platform (TeraRecon AV), offers flexibility for multi-site deployment with its DICOM interoperability and ability to integrate with existing PACS, RIS, and EMR systems.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

Backers

Who funded each tool's parent company.